Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17021.85 236.20 NIFTY 5052.45 63.45
 

Glenmark Pharma Half Yearly Results, Glenmark Pharma Financial Statement & Accounts

Glenmark Pharma

BSE: 532296  |  NSE: GLENMARK  |  ISIN: INE935A01035  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Half Yearly Results of Glenmark Pharma

------------------- in Rs. Cr. -------------------
Sep '07 Mar '08 Sep '08 Mar '09 Sep '09
6 mths 6 mths 6 mths 6 mths 6 mths
Sales Turnover 542.21 830.48 420.00 435.93 456.20
Other Income 2.78 17.27 25.79 73.07 4.49
Total Income 544.99 847.75 445.79 509.00 460.69
Total Expenses 370.90 520.07 296.71 337.46 386.99
Operating Profit 171.31 310.41 123.29 98.47 69.21
Profit On Sale Of Assets -- -- -- -- --
Profit On Sale Of Investments -- -- -- -- --
Gain/Loss On Foreign Exchange -- -- -- -- --
VRS Adjustment -- -- -- -- --
Other Extraordinary Income/Expenses -- -- -- -- --
Total Extraordinary Income/Expenses -- -- -0.30 -- --
Tax On Extraordinary Items -- -- -- -- --
Net Extra Ordinary Income/Expenses -- -- -- -- --
Gross Profit 174.09 327.68 149.08 171.54 73.70
Interest 20.22 20.91 25.42 29.72 9.40
PBDT 153.87 306.77 123.35 141.81 64.30
Depreciation 13.50 15.95 8.93 10.17 10.58
Depreciation On Revaluation Of Assets -- -- -- -- --
PBT 140.37 290.82 114.42 131.64 53.72
Tax 27.91 14.25 -9.30 37.44 -9.00
Net Profit 112.46 276.57 123.72 94.20 62.72
Prior Year Income/Expenses -- -- -- -- --
Depreciation for Previous Years Written Back/ Provided -- -- -- -- --
Dividend -- -- -- -- --
Dividend Tax -- -- -- -- --
Dividend (%) -- -- -- -- --
Earnings Per Share(Rs) 9.22 22.24 4.94 3.76 2.33
Book Value(Rs) -- -- -- -- --
Equity 24.39 24.87 25.02 25.05 26.96
Reserves -- 1,003.38 -- 1,204.92 --
Face Value(Rs) 2.00 2.00 1.00 1.00 1.00
Source : Religare Technova
Explore Glenmark connections